Hypoxemia

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Procedural Oxygen MaskN/A1 trial
Active Trials
NCT07234188RecruitingEst. May 2026
NK
Nihon KohdenNEW YORK, NY
1 program
Pulse oximeterN/A1 trial
Active Trials
NCT07168798Enrolling By InvitationEst. Nov 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
City TherapeuticsProcedural Oxygen Mask
Nihon KohdenPulse oximeter

Clinical Trials (2)

NCT07234188City TherapeuticsProcedural Oxygen Mask

POM vs HFNC for Hypoxemia Prevention in Children

Start: Mar 2026Est. completion: May 2026
N/ARecruiting
NCT07168798Nihon KohdenPulse oximeter

SpO2 Accuracy in Children

Start: Nov 2025Est. completion: Nov 2028
N/AEnrolling By Invitation

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space